Viridian Therapeutics March 2022 %VIRIDIAN Cautionary note regarding forward-looking statements This presentation contains forward-looking statements relating to Viridian Therapeutics, Inc., including statements about our plans to obtain funding, develop and commercialize our therapeutic candidates, our planned clinical trials, the timing of and our ability to obtain and maintain regulatory approvals for our therapeutic candidates, the clinical utility of our therapeutic candidates and our intellectual prop ...

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q4 2021 Earnings Conference Call March 10, 2022 4:30 PM ET Company Participants John Jordan – Vice President-Investor Relations and Corporate Communications Jonathan Violin – President and Chief Executive Officer Kristian Humer – Chief Financial Officer and Chief Business Officer Conference Call Participants Chris Howerton – Jefferies Thomas Smith – SVB Leerink JP Solomon – Evercore ISI Rami Katkhuda – LifeSci Capital Laura Chico – Wedbush Jason Butler – JMP Securit ...

Viridian Therapeutics June 2021 Cautionary note regarding forward-looking statements This presentation contains forward-looking statements relating to Viridian Therapeutics, Inc., including statements about our plans to obtain funding, develop and commercialize our therapeutic candidates, our planned clinical trials, the timing of and our ability to obtain and maintain regulatory approvals for our therapeutic candidates, the clinical utility of our therapeutic candidates and our intellectual property positi ...

miRagen Therapeutics, Inc. (MGEN) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Dan Ferry – Managing Director-LifeSci Advisors Bill Marshall – President and Chief Executive Officer Diana Escolar – Chief Medical Officer Jason Leverone – Chief Financial Officer Conference Call Participants Jonathan Miller – Evercore ISI Andreas Argyrides – Wedbush Securities Trevor Allred – Oppenheimer Operator Greetings, and welcome to the miRagen Therapeutics Q2 2020 Earnings Conference Cal ...

Restoring Biological Harmony for Patients with Debilitating Disease 1 miRagen Therapeutics NASDAQ: MGEN Jefferies Virtual Healthcare Conference June 2 – June 4, 2020 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements relating to Miragen Therapeutics, Inc., including statements about our plans to obtain funding, develop and commercialize our therapeutic candidates, our planned clinical trials, the timing of and our ability to obtain and maintain regulat ...

Miragen Therapeutics, Inc. (MGEN) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Dan Ferry - Managing Director of LifeSci Advisors Bill Marshall - President & Chief Executive Officer Jason Leverone - Chief Financial Officer Conference Call Participants Liana Moussatos - Wedbush Securities Leland Gershell - Oppenheimer Jonathan Miller - Evercore ISI Operator Greetings and welcome to the Miragen Therapeutics First Quarter 2020 Earnings Conference Call. At this time, all participa ...

miRagen Therapeutics, Inc. (MGEN) Q4 2019 Earnings Conference Call March 11, 2020 4:30 PM ET Company Participants Dan Ferry - Managing Director of LifeSci Advisors Bill Marshall - President and CEO Diana Escolar - Chief Medical Officer Jason Leverone - CFO Conference Call Participants Kambiz Yazdi - Wedbush Securities Jonathan Miller - Evercore ISI Operator Greetings. Welcome to miRagen Therapeutics Fourth Quarter 2019 Earnings Call. [Operator Instructions] Please note this conference is being recorded. I w ...

miRagen Therapeutics, Inc. (MGEN) Q3 2019 Earnings Conference Call November 7, 2019 4:30 PM ET Company Participants Dan Ferry – Managing Director of LifeSci Advisors Bill Marshall – President and Chief Executive Officer Jason Leverone – Chief Financial Officer Conference Call Participants Jonathan Miller – Evercore ISI Leland Gershell – Oppenheimer Madhu Kumar – R.W. Baird Liana Moussatos – Wedbush Securities Operator Thank you for standing by. This is the conference operator. Welcome to the miRagen Therape ...

miRagen Therapeutics, Inc. (MGEN) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Dan Ferry – Managing Director-LifeSci Advisors, LLC Bill Marshall – President and Chief Executive Officer Jason Leverone – Chief Financial Officer Conference Call Participants Liana Moussatos – Wedbush Securities Jonathan Miller – Evercore ISI Jennifer Grayson – R. W. Baird Leland Gershell – Oppenheimer Suji Jeong – Jefferies Operator Greetings and welcome to the miRagen Therapeutics’ Q2 2019 Ea ...

Restoring Biological Harmony for Patients with Debilitating Disease Pg. 1 miRagen Therapeutics NASDAQ: MGEN Jefferies 2019 Healthcare Conference June 2019 Cautionary Note Regarding Forward-Looking Statements Pg. 2 This presentation contains forward-looking statements relating to Miragen Therapeutics, Inc., including statements about our plans to obtain funding, develop and commercialize our therapeutic candidates, our planned clinical trials, the timing of and our ability to obtain and maintain regulatory a ...